MedPath

GALDERMA LABORATORIES, L.P.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

21

FDA:21

Drug Approvals

DIFFERIN

Approval Date
Dec 27, 2023
FDA

METROGEL

Approval Date
Nov 27, 2023
FDA

AKLIEF

Approval Date
Oct 31, 2023
FDA

Dysport

Approval Date
Sep 30, 2023
FDA

TRI-LUMA

Approval Date
Aug 22, 2023
FDA

TWYNEO

Approval Date
Jul 11, 2023
FDA

Differin

Approval Date
Apr 19, 2023
FDA

EPSOLAY

Approval Date
Apr 12, 2023
FDA

CLOBEX

Approval Date
Feb 2, 2023
FDA

Clobex

Approval Date
Jan 31, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy